文献速递自身免疫性与大疱性皮肤病

转录组分析揭示细胞组成参与单中心Castleman病相关副肿瘤性天疱疮的透明血管型变异

Transcriptome profiling reveals that cellular composition contributes to the hyaline-vascular variant in unicentric Castleman disease-associated paraneoplastic pemphigus.
PubMed 文献 · Br J Dermatol · 2026-01-01

本研究对33例病理确诊的UCD-PNP患者淋巴结行批量RNA测序,其中5例行单细胞RNA测序。结果显示细胞外基质失调、内皮细胞扩展及内皮细胞与B细胞交互驱动血管透明化和炎症信号,提示靶向内皮细胞-免疫交互是潜在治疗策略。

要点

  • UCD-PNP中胶原基因显著上调,内皮细胞是胶原和层粘连蛋白过表达的主要来源。
  • 内皮细胞通过COL4A1-CD44与B细胞交互,促进基底膜积累和促炎因子释放。
  • 滤泡树突状细胞减少,内皮细胞扩展驱动血管透明化,靶向该交互或为新策略。

核心结论

  • UCD-PNP发病核心在于内皮细胞异常扩展和失调,通过过度ECM沉积驱动血管透明化。
  • 病理性的内皮细胞-B细胞交互直接将基底膜积累与促炎信号联系起来。
  • 靶向内皮细胞驱动的基质-免疫交互是UCD-PNP的新型治疗策略。

研究设计与样本

  • 对33例病理确诊的UCD-PNP患者淋巴结样本行批量RNA测序,其中5例行单细胞RNA测序(scRNAseq)。
  • 分析包括差异表达、通路富集、细胞解卷积、发育轨迹推断、配体-受体互作分析和空间验证。
  • 利用批量RNAseq和蛋白质组学分析评估所识别互作的功能后果。

主要发现

  • 批量RNAseq显示ECM失调,UCD-PNP中胶原基因显著上调。
  • scRNAseq分析58 811个细胞,显示内皮细胞、周细胞和成纤维细胞扩展,滤泡树突状细胞减少。
  • 细胞间通讯分析识别内皮细胞通过COL4A1-ITGA1/ITGB1和LAMB1-ITGA6/ITGB1信号主要贡献胶原和层粘连蛋白过表达。
  • UCD-PNP特征包括浆母细胞显著扩展、IgG类别转换和记忆CD4+ T细胞驱动B细胞过度活跃。
  • 配体-受体分析显示内皮细胞来源的COL4A1与B细胞上的CD44关键互作。

临床怎么用

  • UCD-PNP治疗或需同时靶向内皮细胞和免疫系统,而非仅免疫抑制。
  • 内皮细胞-B细胞交互中的COL4A1-CD44信号可作为潜在治疗靶点。

局限性

  • 未来需在动物研究中验证这些发现。
  • 需进一步研究其他免疫细胞如何参与疾病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Unicentric Castleman disease (UCD), a rare lymphoproliferative disorder, is frequently complicated by paraneoplastic pemphigus (PNP), an autoimmune mucocutaneous syndrome with high mortality. The hyaline-vascular (HV) histological subtype predominates in UCD-PNP, yet the mechanisms driving vascular hyalinization and stromal dysregulation remain poorly defined. OBJECTIVES: To elucidate the cellular and molecular pathogenesis of UCD-PNP through integrated transcriptomic and cellular analyses, focusing on stromal-immune crosstalk and mechanisms underlying extracellular matrix (ECM) dysregulation. METHODS: We performed bulk RNA sequencing (RNAseq) of lymph node samples from 33 patients with pathologically confirmed UCD-PNP and single-cell RNAseq (scRNAseq) in 5 of them. Analytical approaches included differential expression, pathway enrichment, cellular deconvolution, developmental trajectory inference, ligand-receptor interaction analysis and spatial validation. The functional consequences of identified interactions were assessed using bulk RNAseq and proteomic analysis. RESULTS: Bulk RNAseq highlighted ECM dysregulation, with significant upregulation of collagen genes in UCD-PNP. scRNAseq of 58 811 cells revealed expansion of endothelial cells (ECs), pericytes and fibroblasts, alongside diminished follicular dendritic cells (FDCs). Cell-cell communication analysis identified ECs as primary contributors to collagen and laminin overproduction via COL4A1-ITGA1/ITGB1 and LAMB1-ITGA6/ITGB1 signalling, directly linking EC activity to perivascular hyalinization. UCD-PNP also featured marked plasmablast expansion, IgG class-switching and memory CD4+ T cells driving B-cell hyperactivity. In addition, ligand-receptor analysis revealed a pivotal interaction between EC-derived COL4A1 and CD44 on B cells. Mechanistically, COL4A1 overexpression in ECs upregulated genes involved in ECM organization and remodelling. Furthermore, proteomics revealed EC-B-cell crosstalk-derived vascular basement membrane accumulation (perlecan, encoded by HSPG2) and proinflammatory cytokine release (CCL4) in functional co-cultures. CONCLUSIONS: UCD-PNP pathogenesis centres on aberrant EC expansion and dysregulation, driving simultaneous vascular hyalinization via excessive ECM deposition. Pathological EC-B-cell interactions directly link basement membrane accumulation to proinflammatory signalling. Targeting this EC-driven stromal-immune crosstalk presents a novel therapeutic strategy for UCD-PNP. Unicentric Castleman disease (UCD) is a rare disease. It involves one enlarged lymph node in the body. Lymph nodes are small structures in the body that have an important role in the immune system. Another disease called ‘paraneoplastic pemphigus’ (PNP) is a life-threatening condition. In PNP, a person’s immune system attacks their skin, mucous membranes and lungs. When a patient has both UCD and PNP (UCD-PNP), it can be very serious and challenging for doctors to treat. In this study, we wanted to find out which cells in an affected lymph node are involved in forming the thickened blood vessels seen in people with UCD-PNP. We also wanted to understand what links the abnormal lymph node to the immune system’s dysfunction in the disease. We used advanced technology to see how different cells in the lymph node ‘talk’ to one another. We found that blood vessel cells are not just structural, but are also actively involved in the disease. We also found that these vessels become hyperactive and start pumping out proteins (like collagen). A specific ‘conversation’ takes place where blood vessel cells signal to a type of immune cells called B cells. The blood vessel cells ‘instruct’ B cells to release inflammatory chemicals and harmful antibodies in the body. Finally, support cells called ‘follicular dendritic cells’ lose their normal function. This can cause tissue damage. Our findings suggest that treating UCD-PNP requires more than just suppressing the immune system. Doctors may also need to target blood vessels. Future research should test these ideas in animal studies. They should also investigate how other immune cells can contribute to the disease.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Wang S, Wang R, Yang Y, et al. Transcriptome profiling reveals that cellular composition contributes to the hyaline-vascular variant in unicentric Castleman disease-associated paraneoplastic pemphigus. Br J Dermatol. 2026. PMID: 42008118. doi:10.1093/bjd/ljag153

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。